Future directions in cancer treatment: focus on tumor microenvironment
Treating early stage melanoma
Testing novel biomarkers for treatment
PROs of the ProtecT trial: is using data provided by patients a good tool for counselling?
Effect of cabozantinib on quality of life in renal cell carcinoma